Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes. (2015)
Attributed to:
Development of tumour-targeted gene delivery systems for intravenous cancer therapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.nano.2015.04.006
PubMed Identifier: 25933695
Publication URI: http://europepmc.org/abstract/MED/25933695
Type: Journal Article/Review
Volume: 11
Parent Publication: Nanomedicine : nanotechnology, biology, and medicine
Issue: 6
ISSN: 1549-9634